Weight-loss drug cuts heart attack risk regardless of kilograms shed, study finds
by Andrew Gregory Health editor from Science | The Guardian on (#70YQG)
Semaglutide study suggests such drugs could have wider benefits, though researchers find shrinking waistlines linked to better heart outcomes
The weight-loss drug semaglutide cuts the risk of heart attack or stroke regardless of how many kilograms people lose, the largest study of its kind has found.
However, shrinking waist size - a sign of less belly fat - was linked to better heart outcomes, according to the research.
Continue reading...